Balancing efficacy and toxicity in kidney-transplant immunosuppression

New England Journal of Medicine

Volumn 357, Issue 25, 2007, Pages 2625-2627

  Leichtman, Alan B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETABOLITE; AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; DACLIZUMAB; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; CLINICAL PROTOCOL; COMBINATION CHEMOTHERAPY; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DIARRHEA; DRUG EFFICACY; EDITORIAL; GASTROINTESTINAL TOXICITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME;

EID: 37349047937     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe078181     Document Type: Editorial

References (9)

1. Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004;351:2715-29. [Erratum, N Engl J Med 2005;352:1056.]
2. Ekberg H, Tedesco-Silva H, Demirbas A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007;357:2562-75.
3. Vincenti F, Laskow DA, Neylan JF, Mendez R, Matas AJ. One-year follow-up of an open-label trial of FK506 for primary kidney transplantation: a report of the U.S. Multicenter FK506 Kidney Transplant Group. Transplantation 1996;61:1576-81.
4. Kaplan B, Schold JD, Meier-Kriesche HU. Long-term graft survival with Neoral and tacrolimus: a paired kidney analysis. J Am Soc Nephrol 2003;14:2980-4.
5. Scientific Registry of Transplant Recipients. National reports. (Accessed November 29, 2007, at http://www.ustransplant.org/csr/current/nats.aspx.)
6. Neylan JF. Immunosuppressive therapy in high-risk transplant patients: dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients. Transplantation 1997;64:1277-82.
7. 7. Idem. Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. Transplantation 1998;65:515-23.
8. Naito T, Shinno K, Maeda T, et al. Effects of calcineurin inhibitors on pharmacokinetics of mycophenolic acid and its glucuronide metabolite during the maintenance period following renal transplantation. Biol Pharm Bull 2006;29:275-80.
9. Filler G. Value of therapeutic drug monitoring of MMF therapy in pediatric transplantation. Pediatr Transplant 2006;10:707-11.